Skip to main content
Erschienen in: Surgery Today 2/2015

01.02.2015 | Original Article

Clinical features of multiple lung cancers based on thin-section computed tomography: What are the appropriate surgical strategies for second lung cancers?

verfasst von: Aritoshi Hattori, Kenji Suzuki, Kazuya Takamochi, Shiaki Oh

Erschienen in: Surgery Today | Ausgabe 2/2015

Einloggen, um Zugang zu erhalten

Abstract

Purpose

We investigated the proper surgical strategies for second lung cancers based on the findings of thin-section CT.

Methods

We classified 59 patients with second lung cancers into two categories based on the thin-section CT findings. In the ground glass nodule (GGN) group (n = 29), the first and/or the second lung cancers showed a GGN on thin-section CT. In the Solid group (n = 30), both the first and second lung cancers showed a solid appearance.

Results

The overall 5-year survival rate after second surgery was 71.7 %. The univariate analyses revealed that the presence of more than three lung tumors was significantly more common in the GGN group. Regarding the surgical strategies, all the patients in the GGN group underwent limited resection for at least one of the operations, whereas 36 % of those in the Solid group underwent bilateral lobectomy. The 5-year survival in the GGN group (89.1 %) was significantly better than that in the Solid group (40.8 %) (p = 0.0305).

Conclusions

Limited resection should be performed for GGN patients as much as possible to preserve lung function, due to the possible presence of more than three lung cancers. Despite the higher likelihood of having more tumors, the GGN patients had a better survival. In contrast, lobectomy for second lesions should be aggressively considered for solid tumor patients whenever possible.
Literatur
1.
Zurück zum Zitat Surapaneni R, Singh P, Rajagopalan K, Hageboutros A. Stage I lung cancer survivorship: risk of second malignancies and need for individualized care plan. J Thorac Oncol. 2012;7(8):1252–6.PubMedCrossRef Surapaneni R, Singh P, Rajagopalan K, Hageboutros A. Stage I lung cancer survivorship: risk of second malignancies and need for individualized care plan. J Thorac Oncol. 2012;7(8):1252–6.PubMedCrossRef
2.
Zurück zum Zitat Johnson BE. Second lung cancers in patients after treatment for an initial lung cancer. J Natl Cancer Inst. 1998;90(18):1335–45.PubMedCrossRef Johnson BE. Second lung cancers in patients after treatment for an initial lung cancer. J Natl Cancer Inst. 1998;90(18):1335–45.PubMedCrossRef
3.
Zurück zum Zitat Shah AA, Barfield ME, Kelsey CR, Onaitis MW, Tong B, Harpole D, et al. Outcomes after surgical management of synchronous bilateral primary lung cancers. Ann Thorac Surg. 2012;93(4):1055–60 (discussion 1060).PubMedCrossRef Shah AA, Barfield ME, Kelsey CR, Onaitis MW, Tong B, Harpole D, et al. Outcomes after surgical management of synchronous bilateral primary lung cancers. Ann Thorac Surg. 2012;93(4):1055–60 (discussion 1060).PubMedCrossRef
4.
Zurück zum Zitat Fabian T, Bryant AS, Mouhlas AL, Federico JA, Cerfolio RJ. Survival after resection of synchronous non-small cell lung cancer. J Thorac Cardiovasc Surg. 2011;142(3):547–53.PubMedCrossRef Fabian T, Bryant AS, Mouhlas AL, Federico JA, Cerfolio RJ. Survival after resection of synchronous non-small cell lung cancer. J Thorac Cardiovasc Surg. 2011;142(3):547–53.PubMedCrossRef
5.
Zurück zum Zitat De Leyn P, Moons J, Vansteenkiste J, Verbeken E, Van Raemdonck D, Nafteux P, et al. Survival after resection of synchronous bilateral lung cancer. Eur J Cardiothorac Surg. 2008;34(6):1215–22.PubMedCrossRef De Leyn P, Moons J, Vansteenkiste J, Verbeken E, Van Raemdonck D, Nafteux P, et al. Survival after resection of synchronous bilateral lung cancer. Eur J Cardiothorac Surg. 2008;34(6):1215–22.PubMedCrossRef
6.
Zurück zum Zitat Tsunezuka Y, Matsumoto I, Tamura M, Oda M, Ohta Y, Shimizu J, et al. The results of therapy for bilateral multiple primary lung cancers: 30 years experience in a single centre. Eur J Surg Oncol. 2004;30(7):781–5.PubMedCrossRef Tsunezuka Y, Matsumoto I, Tamura M, Oda M, Ohta Y, Shimizu J, et al. The results of therapy for bilateral multiple primary lung cancers: 30 years experience in a single centre. Eur J Surg Oncol. 2004;30(7):781–5.PubMedCrossRef
7.
Zurück zum Zitat Aziz TM, Saad RA, Glasser J, Jilaihawi AN, Prakash D. The management of second primary lung cancers. A single centre experience in 15 years. Eur J Cardiothorac Surg. 2002;21(3):527–33.PubMedCrossRef Aziz TM, Saad RA, Glasser J, Jilaihawi AN, Prakash D. The management of second primary lung cancers. A single centre experience in 15 years. Eur J Cardiothorac Surg. 2002;21(3):527–33.PubMedCrossRef
8.
Zurück zum Zitat Adebonojo SA, Moritz DM, Danby CA. The results of modern surgical therapy for multiple primary lung cancers. Chest. 1997;112(3):693–701.PubMedCrossRef Adebonojo SA, Moritz DM, Danby CA. The results of modern surgical therapy for multiple primary lung cancers. Chest. 1997;112(3):693–701.PubMedCrossRef
9.
Zurück zum Zitat Angeletti CA, Mussi A, Janni A, Lucchi M, Ribechini A, Chella A, et al. Second primary lung cancer and relapse: treatment and follow-up. Eur J Cardiothorac Surg. 1995;9(11):607–11.PubMedCrossRef Angeletti CA, Mussi A, Janni A, Lucchi M, Ribechini A, Chella A, et al. Second primary lung cancer and relapse: treatment and follow-up. Eur J Cardiothorac Surg. 1995;9(11):607–11.PubMedCrossRef
10.
Zurück zum Zitat Chang YL, Wu CT, Lee YC. Surgical treatment of synchronous multiple primary lung cancers: experience of 92 patients. J Thorac Cardiovasc Surg. 2007;134(3):630–7.PubMedCrossRef Chang YL, Wu CT, Lee YC. Surgical treatment of synchronous multiple primary lung cancers: experience of 92 patients. J Thorac Cardiovasc Surg. 2007;134(3):630–7.PubMedCrossRef
11.
Zurück zum Zitat Deschamps C, Pairolero PC, Trastek VF, Payne WS. Multiple primary lung cancers. Results of surgical treatment. J Thorac Cardiovasc Surg. 1990;99(5):769–77 (discussion 777–778).PubMed Deschamps C, Pairolero PC, Trastek VF, Payne WS. Multiple primary lung cancers. Results of surgical treatment. J Thorac Cardiovasc Surg. 1990;99(5):769–77 (discussion 777–778).PubMed
12.
Zurück zum Zitat Rea F, Zuin A, Callegaro D, Bortolotti L, Guanella G, Sartori F. Predictors of outcomes after surgical treatment of synchronous primary lung cancers. J Thorac Oncol. 2010;5(2):197–205.CrossRef Rea F, Zuin A, Callegaro D, Bortolotti L, Guanella G, Sartori F. Predictors of outcomes after surgical treatment of synchronous primary lung cancers. J Thorac Oncol. 2010;5(2):197–205.CrossRef
13.
Zurück zum Zitat Nakata M, Sawada S, Yamashita M, Saeki H, Kurita A, Takashima S, et al. Surgical treatments for multiple primary adenocarcinoma of the lung. Ann Thorac Surg. 2004;78(4):1194–9.PubMedCrossRef Nakata M, Sawada S, Yamashita M, Saeki H, Kurita A, Takashima S, et al. Surgical treatments for multiple primary adenocarcinoma of the lung. Ann Thorac Surg. 2004;78(4):1194–9.PubMedCrossRef
14.
Zurück zum Zitat Okada M, Tsubota N, Yoshimura M, Miyamoto Y. Operative approach for multiple primary lung carcinomas. J Thorac Cardiovasc Surg. 1998;115(4):836–40.PubMedCrossRef Okada M, Tsubota N, Yoshimura M, Miyamoto Y. Operative approach for multiple primary lung carcinomas. J Thorac Cardiovasc Surg. 1998;115(4):836–40.PubMedCrossRef
15.
Zurück zum Zitat Rea F, Zuin A, Callegaro D, Bortolotti L, Guanella G, Sartori F. Surgical results for multiple primary lung cancers. Eur J Cardiothorac Surg. 2001;20(3):489–95.PubMedCrossRef Rea F, Zuin A, Callegaro D, Bortolotti L, Guanella G, Sartori F. Surgical results for multiple primary lung cancers. Eur J Cardiothorac Surg. 2001;20(3):489–95.PubMedCrossRef
16.
Zurück zum Zitat Trousse D, Barlesi F, Loundou A, Tasei AM, Doddoli C, Giudicelli R, et al. Synchronous multiple primary lung cancer: an increasing clinical occurrence requiring multidisciplinary management. J Thorac Cardiovasc Surg. 2007;133(5):1193–200.PubMedCrossRef Trousse D, Barlesi F, Loundou A, Tasei AM, Doddoli C, Giudicelli R, et al. Synchronous multiple primary lung cancer: an increasing clinical occurrence requiring multidisciplinary management. J Thorac Cardiovasc Surg. 2007;133(5):1193–200.PubMedCrossRef
17.
Zurück zum Zitat Bae MK, Byun CS, Lee CY, Lee JG, Park IK, Kim DJ, et al. The role of surgical treatment in second primary lung cancer. Ann Thorac Surg. 2011;92(1):256–62.PubMedCrossRef Bae MK, Byun CS, Lee CY, Lee JG, Park IK, Kim DJ, et al. The role of surgical treatment in second primary lung cancer. Ann Thorac Surg. 2011;92(1):256–62.PubMedCrossRef
18.
Zurück zum Zitat Martini N, Melamed MR. Multiple primary lung cancers. J Thorac Cardiovasc Surg. 1975;70(4):606–12.PubMed Martini N, Melamed MR. Multiple primary lung cancers. J Thorac Cardiovasc Surg. 1975;70(4):606–12.PubMed
19.
Zurück zum Zitat Mitsudomi T, Yatabe Y, Koshikawa T, Hatooka S, Shinoda M, Suyama M, et al. Mutations of the P53 tumor suppressor gene as clonal marker for multiple primary lung cancers. J Thorac Cardiovasc Surg. 1997;114(3):354–60.PubMedCrossRef Mitsudomi T, Yatabe Y, Koshikawa T, Hatooka S, Shinoda M, Suyama M, et al. Mutations of the P53 tumor suppressor gene as clonal marker for multiple primary lung cancers. J Thorac Cardiovasc Surg. 1997;114(3):354–60.PubMedCrossRef
20.
Zurück zum Zitat Matsuzoe D, Hideshima T, Ohshima K, Kawahara K, Shirakusa T, Kimura A. Discrimination of double primary lung cancer from intrapulmonary metastasis by p53 gene mutation. Br J Cancer. 1999;79(9–10):1549–52.PubMedCentralPubMedCrossRef Matsuzoe D, Hideshima T, Ohshima K, Kawahara K, Shirakusa T, Kimura A. Discrimination of double primary lung cancer from intrapulmonary metastasis by p53 gene mutation. Br J Cancer. 1999;79(9–10):1549–52.PubMedCentralPubMedCrossRef
21.
Zurück zum Zitat Girard N, Deshpande C, Azzoli CG, Rusch VW, Travis WD, Ladanyi M, et al. Use of epidermal growth factor receptor/Kirsten rat sarcoma 2 viral oncogene homolog mutation testing to define clonal relationships among multiple lung adenocarcinomas: comparison with clinical guidelines. Chest. 2010;137(1):46–52.PubMedCrossRef Girard N, Deshpande C, Azzoli CG, Rusch VW, Travis WD, Ladanyi M, et al. Use of epidermal growth factor receptor/Kirsten rat sarcoma 2 viral oncogene homolog mutation testing to define clonal relationships among multiple lung adenocarcinomas: comparison with clinical guidelines. Chest. 2010;137(1):46–52.PubMedCrossRef
22.
Zurück zum Zitat Antakli T, Schaefer RF, Rutherford JE, Read RC. Second primary lung cancer. Ann Thorac Surg. 1995;59(4):863–6 (discussion 867).PubMedCrossRef Antakli T, Schaefer RF, Rutherford JE, Read RC. Second primary lung cancer. Ann Thorac Surg. 1995;59(4):863–6 (discussion 867).PubMedCrossRef
23.
Zurück zum Zitat Asamura H. Multiple primary cancers or multiple metastases, that is the question. J Thorac Oncol. 2010;5(7):930–1.PubMedCrossRef Asamura H. Multiple primary cancers or multiple metastases, that is the question. J Thorac Oncol. 2010;5(7):930–1.PubMedCrossRef
24.
Zurück zum Zitat Suzuki K, Kusumoto M, Watanabe S, Tsuchiya R, Asamura H. Radiologic classification of small adenocarcinoma of the lung: radiologic–pathologic correlation and its prognostic impact. Ann Thorac Surg. 2006;81:413–9.PubMedCrossRef Suzuki K, Kusumoto M, Watanabe S, Tsuchiya R, Asamura H. Radiologic classification of small adenocarcinoma of the lung: radiologic–pathologic correlation and its prognostic impact. Ann Thorac Surg. 2006;81:413–9.PubMedCrossRef
25.
Zurück zum Zitat Hattori A, Suzuki K, Matsunaga T, Fukui M, Kitamura Y, Miyasaka Y, et al. Is limited resection appropriate for radiologically “solid” tumors in small lung cancers? Ann Thorac Surg. 2012;94:212–5.PubMedCrossRef Hattori A, Suzuki K, Matsunaga T, Fukui M, Kitamura Y, Miyasaka Y, et al. Is limited resection appropriate for radiologically “solid” tumors in small lung cancers? Ann Thorac Surg. 2012;94:212–5.PubMedCrossRef
Metadaten
Titel
Clinical features of multiple lung cancers based on thin-section computed tomography: What are the appropriate surgical strategies for second lung cancers?
verfasst von
Aritoshi Hattori
Kenji Suzuki
Kazuya Takamochi
Shiaki Oh
Publikationsdatum
01.02.2015
Verlag
Springer Japan
Erschienen in
Surgery Today / Ausgabe 2/2015
Print ISSN: 0941-1291
Elektronische ISSN: 1436-2813
DOI
https://doi.org/10.1007/s00595-014-0921-5

Weitere Artikel der Ausgabe 2/2015

Surgery Today 2/2015 Zur Ausgabe

Leitlinien kompakt für die Allgemeinmedizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Facharzt-Training Allgemeinmedizin

Die ideale Vorbereitung zur anstehenden Prüfung mit den ersten 24 von 100 klinischen Fallbeispielen verschiedener Themenfelder

Mehr erfahren

Reizdarmsyndrom: Diäten wirksamer als Medikamente

29.04.2024 Reizdarmsyndrom Nachrichten

Bei Reizdarmsyndrom scheinen Diäten, wie etwa die FODMAP-arme oder die kohlenhydratreduzierte Ernährung, effektiver als eine medikamentöse Therapie zu sein. Das hat eine Studie aus Schweden ergeben, die die drei Therapieoptionen im direkten Vergleich analysierte.

Akuter Schwindel: Wann lohnt sich eine MRT?

28.04.2024 Schwindel Nachrichten

Akuter Schwindel stellt oft eine diagnostische Herausforderung dar. Wie nützlich dabei eine MRT ist, hat eine Studie aus Finnland untersucht. Immerhin einer von sechs Patienten wurde mit akutem ischämischem Schlaganfall diagnostiziert.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

25.04.2024 Hypertonie Nachrichten

Beginnen ältere Männer im Pflegeheim eine Antihypertensiva-Therapie, dann ist die Frakturrate in den folgenden 30 Tagen mehr als verdoppelt. Besonders häufig stürzen Demenzkranke und Männer, die erstmals Blutdrucksenker nehmen. Dafür spricht eine Analyse unter US-Veteranen.

Update Allgemeinmedizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.